MELD Score as a Prognostic Model for Listing Acute Liver Failure Patients for Liver Transplantation

The King’s College Hospital (KCH) criteria are widely used for listing patients with acute liver failure (ALF) for liver transplantation (LT). Recent reports have suggested that the Model for End-Stage Liver Disease (MELD) score may be useful in assessing prognosis in ALF (nonparacetamol). This stud...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Transplantation proceedings 2006-09, Vol.38 (7), p.2097-2098
Hauptverfasser: Zaman, M.B., Hoti, E., Qasim, A., Maguire, D., McCormick, P.A., Hegarty, J.E., Geoghegan, J.G., Traynor, O.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2098
container_issue 7
container_start_page 2097
container_title Transplantation proceedings
container_volume 38
creator Zaman, M.B.
Hoti, E.
Qasim, A.
Maguire, D.
McCormick, P.A.
Hegarty, J.E.
Geoghegan, J.G.
Traynor, O.
description The King’s College Hospital (KCH) criteria are widely used for listing patients with acute liver failure (ALF) for liver transplantation (LT). Recent reports have suggested that the Model for End-Stage Liver Disease (MELD) score may be useful in assessing prognosis in ALF (nonparacetamol). This study compares prognostic accuracy of the two systems in patients with paracetamol (POD)-induced ALF treated in this unit. Seventy-two patients (average age 38 years; F:M ratio 2:1) admitted from 1994 to 2005 with POD-related ALF were studied. Clinical and biochemical parameters were recorded. The effect of applying a MELD score of greater than 30 as listing criteria for LT was calculated and compared with the KCH criteria. Outcomes were defined as LT, death, or full recovery. Thirty-one patients (43%) recovered with medical therapy, 29 (40%) patients died, and 12 (17%) underwent LT. Sixty five percent of patients had a MELD > 30 and therefore could potentially be listed on admission; however, using KCH criteria only 24% patients were listed immediately. Sensitivity and negative predictive value of MELD was higher then KCH; however, we found KCH to have much higher specificity and positive predictive value. MELD has higher sensitivity and negative predictive value for POD-induced ALF than the KCH criteria. However, the high false-positive rate associated with MELD limits its clinical utility. The high negative predictive value of MELD score may allow it to be used in conjunction with KCH criteria to avoid unneeded LT in patients who will likely recover spontaneously.
doi_str_mv 10.1016/j.transproceed.2006.06.004
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68873187</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0041134506006221</els_id><sourcerecordid>68873187</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-b45cf37d1a2f8086bea1cc897785ff669e64505431347a51ce9085709d559b3e3</originalsourceid><addsrcrecordid>eNqNkN9LHDEQgEOx1OvpvyChYN_2THaTbNY38UcrnFRQn0NudlZy7G1skhX875vtLdbHwkDIzDeTyUfIN85WnHF1tl2lYIf4EjwgtquSMbWagolPZMF1XRWlKqsDssgZXvBKyEPyNcYty_dSVF_IIVeNZozzBYG76_UVfQAfkNpILb0P_nnwMTmgd77FnnY-0LXLieGZXsCYMN9eMdAb6_oxd93b5HBIcQan0uPf9Xo7pFzzwxH53Nk-4vF8LsnTzfXj5c9i_evH7eXFugBRi1RshISuqltuy04zrTZoOYBu6lrLrlOqQSUkk6LKP6qt5IAN07JmTStls6mwWpLv-7nZzO8RYzI7FwH7vAj6MRqls5vJz5Kc70EIPsaAnXkJbmfDm-HMTIrN1nxUbCbFZgomcvPJ_Mq42eXae-vsNAOnM2Aj2L7Lg8DFf5zmSjDZZO5qz2F28uowmAjZJGDrAkIyrXf_s88fqdGgcA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68873187</pqid></control><display><type>article</type><title>MELD Score as a Prognostic Model for Listing Acute Liver Failure Patients for Liver Transplantation</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Zaman, M.B. ; Hoti, E. ; Qasim, A. ; Maguire, D. ; McCormick, P.A. ; Hegarty, J.E. ; Geoghegan, J.G. ; Traynor, O.</creator><creatorcontrib>Zaman, M.B. ; Hoti, E. ; Qasim, A. ; Maguire, D. ; McCormick, P.A. ; Hegarty, J.E. ; Geoghegan, J.G. ; Traynor, O.</creatorcontrib><description>The King’s College Hospital (KCH) criteria are widely used for listing patients with acute liver failure (ALF) for liver transplantation (LT). Recent reports have suggested that the Model for End-Stage Liver Disease (MELD) score may be useful in assessing prognosis in ALF (nonparacetamol). This study compares prognostic accuracy of the two systems in patients with paracetamol (POD)-induced ALF treated in this unit. Seventy-two patients (average age 38 years; F:M ratio 2:1) admitted from 1994 to 2005 with POD-related ALF were studied. Clinical and biochemical parameters were recorded. The effect of applying a MELD score of greater than 30 as listing criteria for LT was calculated and compared with the KCH criteria. Outcomes were defined as LT, death, or full recovery. Thirty-one patients (43%) recovered with medical therapy, 29 (40%) patients died, and 12 (17%) underwent LT. Sixty five percent of patients had a MELD &gt; 30 and therefore could potentially be listed on admission; however, using KCH criteria only 24% patients were listed immediately. Sensitivity and negative predictive value of MELD was higher then KCH; however, we found KCH to have much higher specificity and positive predictive value. MELD has higher sensitivity and negative predictive value for POD-induced ALF than the KCH criteria. However, the high false-positive rate associated with MELD limits its clinical utility. The high negative predictive value of MELD score may allow it to be used in conjunction with KCH criteria to avoid unneeded LT in patients who will likely recover spontaneously.</description><identifier>ISSN: 0041-1345</identifier><identifier>EISSN: 1873-2623</identifier><identifier>DOI: 10.1016/j.transproceed.2006.06.004</identifier><identifier>PMID: 16980011</identifier><identifier>CODEN: TRPPA8</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Adult ; Bilirubin - blood ; Biological and medical sciences ; Female ; Fundamental and applied biological sciences. Psychology ; Fundamental immunology ; Gastroenterology. Liver. Pancreas. Abdomen ; Hepatic Encephalopathy - classification ; Hepatic Encephalopathy - mortality ; Hepatic Encephalopathy - surgery ; Humans ; International Normalized Ratio ; Liver Failure, Acute - classification ; Liver Failure, Acute - mortality ; Liver Failure, Acute - surgery ; Liver Failure, Acute - therapy ; Liver Transplantation - statistics &amp; numerical data ; Liver. Biliary tract. Portal circulation. Exocrine pancreas ; Male ; Medical sciences ; Other diseases. Semiology ; Patient Selection ; Prognosis ; Retrospective Studies ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Survival Analysis ; Tissue, organ and graft immunology ; Treatment Outcome ; Waiting Lists</subject><ispartof>Transplantation proceedings, 2006-09, Vol.38 (7), p.2097-2098</ispartof><rights>2006 Elsevier Inc.</rights><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-b45cf37d1a2f8086bea1cc897785ff669e64505431347a51ce9085709d559b3e3</citedby><cites>FETCH-LOGICAL-c474t-b45cf37d1a2f8086bea1cc897785ff669e64505431347a51ce9085709d559b3e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.transproceed.2006.06.004$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>309,310,314,780,784,789,790,3550,23930,23931,25140,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=18164059$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16980011$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zaman, M.B.</creatorcontrib><creatorcontrib>Hoti, E.</creatorcontrib><creatorcontrib>Qasim, A.</creatorcontrib><creatorcontrib>Maguire, D.</creatorcontrib><creatorcontrib>McCormick, P.A.</creatorcontrib><creatorcontrib>Hegarty, J.E.</creatorcontrib><creatorcontrib>Geoghegan, J.G.</creatorcontrib><creatorcontrib>Traynor, O.</creatorcontrib><title>MELD Score as a Prognostic Model for Listing Acute Liver Failure Patients for Liver Transplantation</title><title>Transplantation proceedings</title><addtitle>Transplant Proc</addtitle><description>The King’s College Hospital (KCH) criteria are widely used for listing patients with acute liver failure (ALF) for liver transplantation (LT). Recent reports have suggested that the Model for End-Stage Liver Disease (MELD) score may be useful in assessing prognosis in ALF (nonparacetamol). This study compares prognostic accuracy of the two systems in patients with paracetamol (POD)-induced ALF treated in this unit. Seventy-two patients (average age 38 years; F:M ratio 2:1) admitted from 1994 to 2005 with POD-related ALF were studied. Clinical and biochemical parameters were recorded. The effect of applying a MELD score of greater than 30 as listing criteria for LT was calculated and compared with the KCH criteria. Outcomes were defined as LT, death, or full recovery. Thirty-one patients (43%) recovered with medical therapy, 29 (40%) patients died, and 12 (17%) underwent LT. Sixty five percent of patients had a MELD &gt; 30 and therefore could potentially be listed on admission; however, using KCH criteria only 24% patients were listed immediately. Sensitivity and negative predictive value of MELD was higher then KCH; however, we found KCH to have much higher specificity and positive predictive value. MELD has higher sensitivity and negative predictive value for POD-induced ALF than the KCH criteria. However, the high false-positive rate associated with MELD limits its clinical utility. The high negative predictive value of MELD score may allow it to be used in conjunction with KCH criteria to avoid unneeded LT in patients who will likely recover spontaneously.</description><subject>Adult</subject><subject>Bilirubin - blood</subject><subject>Biological and medical sciences</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Fundamental immunology</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Hepatic Encephalopathy - classification</subject><subject>Hepatic Encephalopathy - mortality</subject><subject>Hepatic Encephalopathy - surgery</subject><subject>Humans</subject><subject>International Normalized Ratio</subject><subject>Liver Failure, Acute - classification</subject><subject>Liver Failure, Acute - mortality</subject><subject>Liver Failure, Acute - surgery</subject><subject>Liver Failure, Acute - therapy</subject><subject>Liver Transplantation - statistics &amp; numerical data</subject><subject>Liver. Biliary tract. Portal circulation. Exocrine pancreas</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Other diseases. Semiology</subject><subject>Patient Selection</subject><subject>Prognosis</subject><subject>Retrospective Studies</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Survival Analysis</subject><subject>Tissue, organ and graft immunology</subject><subject>Treatment Outcome</subject><subject>Waiting Lists</subject><issn>0041-1345</issn><issn>1873-2623</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkN9LHDEQgEOx1OvpvyChYN_2THaTbNY38UcrnFRQn0NudlZy7G1skhX875vtLdbHwkDIzDeTyUfIN85WnHF1tl2lYIf4EjwgtquSMbWagolPZMF1XRWlKqsDssgZXvBKyEPyNcYty_dSVF_IIVeNZozzBYG76_UVfQAfkNpILb0P_nnwMTmgd77FnnY-0LXLieGZXsCYMN9eMdAb6_oxd93b5HBIcQan0uPf9Xo7pFzzwxH53Nk-4vF8LsnTzfXj5c9i_evH7eXFugBRi1RshISuqltuy04zrTZoOYBu6lrLrlOqQSUkk6LKP6qt5IAN07JmTStls6mwWpLv-7nZzO8RYzI7FwH7vAj6MRqls5vJz5Kc70EIPsaAnXkJbmfDm-HMTIrN1nxUbCbFZgomcvPJ_Mq42eXae-vsNAOnM2Aj2L7Lg8DFf5zmSjDZZO5qz2F28uowmAjZJGDrAkIyrXf_s88fqdGgcA</recordid><startdate>20060901</startdate><enddate>20060901</enddate><creator>Zaman, M.B.</creator><creator>Hoti, E.</creator><creator>Qasim, A.</creator><creator>Maguire, D.</creator><creator>McCormick, P.A.</creator><creator>Hegarty, J.E.</creator><creator>Geoghegan, J.G.</creator><creator>Traynor, O.</creator><general>Elsevier Inc</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20060901</creationdate><title>MELD Score as a Prognostic Model for Listing Acute Liver Failure Patients for Liver Transplantation</title><author>Zaman, M.B. ; Hoti, E. ; Qasim, A. ; Maguire, D. ; McCormick, P.A. ; Hegarty, J.E. ; Geoghegan, J.G. ; Traynor, O.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-b45cf37d1a2f8086bea1cc897785ff669e64505431347a51ce9085709d559b3e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adult</topic><topic>Bilirubin - blood</topic><topic>Biological and medical sciences</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Fundamental immunology</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Hepatic Encephalopathy - classification</topic><topic>Hepatic Encephalopathy - mortality</topic><topic>Hepatic Encephalopathy - surgery</topic><topic>Humans</topic><topic>International Normalized Ratio</topic><topic>Liver Failure, Acute - classification</topic><topic>Liver Failure, Acute - mortality</topic><topic>Liver Failure, Acute - surgery</topic><topic>Liver Failure, Acute - therapy</topic><topic>Liver Transplantation - statistics &amp; numerical data</topic><topic>Liver. Biliary tract. Portal circulation. Exocrine pancreas</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Other diseases. Semiology</topic><topic>Patient Selection</topic><topic>Prognosis</topic><topic>Retrospective Studies</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Survival Analysis</topic><topic>Tissue, organ and graft immunology</topic><topic>Treatment Outcome</topic><topic>Waiting Lists</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zaman, M.B.</creatorcontrib><creatorcontrib>Hoti, E.</creatorcontrib><creatorcontrib>Qasim, A.</creatorcontrib><creatorcontrib>Maguire, D.</creatorcontrib><creatorcontrib>McCormick, P.A.</creatorcontrib><creatorcontrib>Hegarty, J.E.</creatorcontrib><creatorcontrib>Geoghegan, J.G.</creatorcontrib><creatorcontrib>Traynor, O.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Transplantation proceedings</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zaman, M.B.</au><au>Hoti, E.</au><au>Qasim, A.</au><au>Maguire, D.</au><au>McCormick, P.A.</au><au>Hegarty, J.E.</au><au>Geoghegan, J.G.</au><au>Traynor, O.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>MELD Score as a Prognostic Model for Listing Acute Liver Failure Patients for Liver Transplantation</atitle><jtitle>Transplantation proceedings</jtitle><addtitle>Transplant Proc</addtitle><date>2006-09-01</date><risdate>2006</risdate><volume>38</volume><issue>7</issue><spage>2097</spage><epage>2098</epage><pages>2097-2098</pages><issn>0041-1345</issn><eissn>1873-2623</eissn><coden>TRPPA8</coden><abstract>The King’s College Hospital (KCH) criteria are widely used for listing patients with acute liver failure (ALF) for liver transplantation (LT). Recent reports have suggested that the Model for End-Stage Liver Disease (MELD) score may be useful in assessing prognosis in ALF (nonparacetamol). This study compares prognostic accuracy of the two systems in patients with paracetamol (POD)-induced ALF treated in this unit. Seventy-two patients (average age 38 years; F:M ratio 2:1) admitted from 1994 to 2005 with POD-related ALF were studied. Clinical and biochemical parameters were recorded. The effect of applying a MELD score of greater than 30 as listing criteria for LT was calculated and compared with the KCH criteria. Outcomes were defined as LT, death, or full recovery. Thirty-one patients (43%) recovered with medical therapy, 29 (40%) patients died, and 12 (17%) underwent LT. Sixty five percent of patients had a MELD &gt; 30 and therefore could potentially be listed on admission; however, using KCH criteria only 24% patients were listed immediately. Sensitivity and negative predictive value of MELD was higher then KCH; however, we found KCH to have much higher specificity and positive predictive value. MELD has higher sensitivity and negative predictive value for POD-induced ALF than the KCH criteria. However, the high false-positive rate associated with MELD limits its clinical utility. The high negative predictive value of MELD score may allow it to be used in conjunction with KCH criteria to avoid unneeded LT in patients who will likely recover spontaneously.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>16980011</pmid><doi>10.1016/j.transproceed.2006.06.004</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0041-1345
ispartof Transplantation proceedings, 2006-09, Vol.38 (7), p.2097-2098
issn 0041-1345
1873-2623
language eng
recordid cdi_proquest_miscellaneous_68873187
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Adult
Bilirubin - blood
Biological and medical sciences
Female
Fundamental and applied biological sciences. Psychology
Fundamental immunology
Gastroenterology. Liver. Pancreas. Abdomen
Hepatic Encephalopathy - classification
Hepatic Encephalopathy - mortality
Hepatic Encephalopathy - surgery
Humans
International Normalized Ratio
Liver Failure, Acute - classification
Liver Failure, Acute - mortality
Liver Failure, Acute - surgery
Liver Failure, Acute - therapy
Liver Transplantation - statistics & numerical data
Liver. Biliary tract. Portal circulation. Exocrine pancreas
Male
Medical sciences
Other diseases. Semiology
Patient Selection
Prognosis
Retrospective Studies
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Survival Analysis
Tissue, organ and graft immunology
Treatment Outcome
Waiting Lists
title MELD Score as a Prognostic Model for Listing Acute Liver Failure Patients for Liver Transplantation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T16%3A45%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=MELD%20Score%20as%20a%20Prognostic%20Model%20for%20Listing%20Acute%20Liver%20Failure%20Patients%20for%20Liver%20Transplantation&rft.jtitle=Transplantation%20proceedings&rft.au=Zaman,%20M.B.&rft.date=2006-09-01&rft.volume=38&rft.issue=7&rft.spage=2097&rft.epage=2098&rft.pages=2097-2098&rft.issn=0041-1345&rft.eissn=1873-2623&rft.coden=TRPPA8&rft_id=info:doi/10.1016/j.transproceed.2006.06.004&rft_dat=%3Cproquest_cross%3E68873187%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68873187&rft_id=info:pmid/16980011&rft_els_id=S0041134506006221&rfr_iscdi=true